Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases,
and it is one of the leading causes of cancer death in both men and women worldwide due …

Although surgical resection with curative intent is the main therapy for both primary and
metastatic lung tumors, about 80% of lung cancers cannot be removed by surgery. Because …

Introduction Our aim was to update global lung cancer epidemiology and describe changing
trends and disparities. Methods We presented country-specific incidence and mortality from …

Purpose: CT screening can reduce death from lung cancer. We sought to improve the
diagnostic accuracy of lung cancer screening using ultrasensitive methods and a lung …

Purpose Stereotactic ablative radiation therapy (SABR) is a guideline-specified treatment
option for early-stage lung cancer. However, significant posttreatment fibrosis can occur and …

Blood-circulating miRNAs could be useful as a biomarker to detect lung cancer early. We
investigated the serum levels of four different miRNAs in patients with non-small cell lung …

There remains tremendous interest in developing liquid biopsy assays for detection of
cancer‐specific alterations, such as mutations and DNA methylation, in cell‐free DNA …

This study was designed to explore the association between elevated platelet to lymphocyte
ratio (PLR) and prognosis of patients with non-small cell lung cancer (NSCLC) by meta …

Background Numerous studies have shown that long non-coding RNAs (lncRNAs) play key
roles during multiple cancer processes, such as cell proliferation, apoptosis, migration and …

Background: A wide variety of myelosuppressive chemotherapy regimens are used for the
treatment of cancer in clinical practice. Neutropenic complications, such as febrile …